For the Inventor, By the Inventor

Enter assignee name

St. Louis, MO, United States of America

Saint Louis University

Calculating rank

USPTO Granted Patents = 224

% Expired Patents = 29.5

CIPO Patents = 7

EPO Patents = 19

Trademarks = 32

Forward Citations = 5,401

Loading Chart...

Loading Chart...

268 inventors (with patents filed for the assignee):

Richard D Bucholz (19 out of 34 patents)

Tomasz Heyduk (17 out of 18 patents)

Shunji Tomatsu (11 out of 14 patents)

4. Daniela Salvemini (10 out of 16 patents)

5. John Edwin Tavis (9 out of 9 patents)

6. Yie-Hwa Chang (9 out of 11 patents)

7. Ling Tian (8 out of 10 patents)

8. Shelley D Minteer (8 out of 12 patents)

9. Marvin Jay Meyers (8 out of 10 patents)

10. Stephen J Barenkamp (7 out of 11 patents)

11. Peter G Ruminski (6 out of 6 patents)

12. Paul Jelliss (6 out of 7 patents)

13. Rajeev Aurora (6 out of 9 patents)

14. Ryan D McCulla (6 out of 6 patents)

15. William S M Wold (6 out of 6 patents)

Core Competencies:

Pulmonary Surfactant

Surgical Tools

Biocompatible Crosslinkers

Enzymatic Digestion

Cancer Treatment

Tissue Regeneration

Nucleotidyltransferase Inhibitors

Antimicrobial Agents

Hydrogel Microspheres

Adenosine Receptor Agonists

Microfluidic Devices

Biosensors

224 patents: Sort by Forward Citations

1. 12642527 - Recirculating distal intestinal content (2026-06-02),

2. 12636290 - BET inhibitors for modulating DUX4 expression in FSHD (2026-05-26),

3. 12616741 - Therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD (2026-05-05),

4. 12570647 - Amino benzothiazole compounds for treatment of antibiotic resistant bacteria (2026-03-10),

5. 12558118 - Systems and methods for guiding surgical tools (2026-02-24),

6. 12502362 - Inhibitors of nucleotidyltransferase superfamily enzymes as antibiotics (2025-12-23),

7. 12398255 - Biocompatible crosslinkers for controlled degradation of polymer hydrogels (2025-08-26),

8. 12397010 - Treatment of chronic headaches (2025-08-26),

9. 12357589 - Inhibitors ofand uses thereof (2025-07-15),

10. 12247053 - Peptides for inducing heterosubtypic influenza T cell responses (2025-03-11),

11. 12195791 - Target enrichment via enzymatic digestion in next generation sequencing (2025-01-14),

12. 12121500 - Inhibitors of Bunyaviridae and uses thereof (2024-10-22),

13. 12054470 - Photoswitchable dibenzothienylmethyl triphenylphosphonium derivatives and methods of treating cancer therewith (2024-08-06),

14. 12048456 - Systems and methods for guiding surgical tools (2024-07-30),

15. 12037327 - Compounds and methods targeting GPER for treatment of diseases associated with calcium (2024-07-16),

Company Overview

Saint Louis University, located in St. Louis, MO, is a prominent institution focused on advancing biomedical innovations. The university specializes in a range of core technology topics, including pulmonary surfactant research, the development of surgical tools, and the creation of biocompatible crosslinkers. Additionally, its research extends to enzymatic digestion, cancer treatment, tissue regeneration, nucleotidyltransferase inhibitors, and antimicrobial agents, contributing significantly to the field of healthcare and medical technology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

224 Patents

#18 in St. Louis, MO

#27 in Missouri

#1,869 in US

#3,817 in the World

St. Louis, MO, United States of America

Saint Louis University

Forward Citations = 5,401

268 inventors:

Richard D Bucholz (19 out of 34 patents)

Tomasz Heyduk (17 out of 18 patents)

Shunji Tomatsu (11 out of 14 patents)

4. Daniela Salvemini (10 out of 16 patents)

5. John Edwin Tavis (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Saint Louis University. Retrieved from https://idiyas.com/company/saint-louis-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…